Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.
In this article we review common methods, comparison between insourcing and outsourcing solutions, and the impact of the surrounding test environment. Learn more here.
Download
Automated disinfection processes, and the regulatory environment in which they operate, have advanced significantly since the previous revision of Annex 1 and in particular three clauses could benefit from technology adoption. Learn more here.
DownloadA world leader in laboratory testing was seeking an alternative to their current isolator, used for sterility testing, due to challenges with bio-decontamination cycle times, employee health and safety, operational and cost concerns, and maintenance issues. See how the Bioquell Qube resolved all of these and more.
View Case Study
EN 17272:2020 is the new European test standard for automated airborne disinfection systems intended to provide a standardised challenge against which manufacturers can test their automated airborne disinfection process to claim defined antimicrobial activity. This paper discusses the background to the development of the standard and provides guidance on its application.
DownloadA Utah fire district faced challenges with the increased cleaning requirements brought about by the COVID-19 pandemic. The district was spending two to three hours disinfecting each vehicle with manual sprays, wipes, and mops. Faced with staff shortages and increased overtime costs, this impeded their ability to turnover vehicles quickly and safely. With all of this in mind, they sought an alternative solution. Using Ecolab's solution, the district was able to significantly reduce the vehicle downtime, placing vehicles back on the road and reducing the labor hours needed for manually cleaning each vehicle and minimizing associated overtime costs.
View Case Study
In 2019, Bioquell, an Ecolab solution, was offered the opportunity to trial its latest development in automated room decontamination technology, the Bioquell ProteQ, at the world renowned St Thomas’ Hospital in London.
During the nine month trial, the Bioquell ProteQ performed over 460 room decontaminations faultlessly, and at one point the system was used non-stop over a 72 hour period to help combat an outbreak on the ICU. By providing 6-log decontamination cycles in patient rooms and larger critical areas like operating theatres, the Bioquell ProteQ played a key role in minimising the spread of healthcare acquired infections within the hospital.
Download